Multidrug-resistant tuberculosis (MDR-TB) accounts for one third of the annual deaths due to antimicrobial resistance. Drug resistance-conferring mutations frequently cause fitness costs in bacteria. Experimental work indicates that these drug resistance-related fitness costs might be mitigated by compensatory mutations.
View Article and Find Full Text PDF